2004
DOI: 10.1007/s00063-004-1091-9
|View full text |Cite
|
Sign up to set email alerts
|

Intensivmedizin 2004

Abstract: The following survey is supposed to present the most important new therapeutic approaches und the current standard of treatment in intensive care medicine including pathophysiological and diagnostic aspects of important diseases, particularly sepsis, septic and cardiogenic shock. Furthermore, advances in the following issues are summarized in detail: ventilation, especially acute respiratory distress syndrome (ARDS) and the broad spectrum of non-invasive ventilation, new therapeutic options in the field of car… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2014
2014

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…HSA may be effective in preventing the hemodynamic derangements associated with total paracentesis or serial large volume paracentesis (Salerno et al, 1987;Luca et al, 1995;Ruiz-del-Arbol et al, 1997;Mendez et al, 2005a) to decrease frequency of renal impairment and mortality in patients with spontaneous bacterial peritonitis (Sort et al, 1999;Mendez et al, 2005a), and, in association with splanchnic vasopressors, in caring for patients with the hepatorenal syndrome (Guevara et al, 1998;Angeli et al, 1999;Duvoux et al, 2002;Reith and Werdan, 2004;Mendez et al, 2005a;Jacob et al, 2008;Vincent, 2009;Polli and Gattinoni, 2010).…”
Section: Human Serum Albumin Administration In Chronic Liver Diseasementioning
confidence: 99%
“…HSA may be effective in preventing the hemodynamic derangements associated with total paracentesis or serial large volume paracentesis (Salerno et al, 1987;Luca et al, 1995;Ruiz-del-Arbol et al, 1997;Mendez et al, 2005a) to decrease frequency of renal impairment and mortality in patients with spontaneous bacterial peritonitis (Sort et al, 1999;Mendez et al, 2005a), and, in association with splanchnic vasopressors, in caring for patients with the hepatorenal syndrome (Guevara et al, 1998;Angeli et al, 1999;Duvoux et al, 2002;Reith and Werdan, 2004;Mendez et al, 2005a;Jacob et al, 2008;Vincent, 2009;Polli and Gattinoni, 2010).…”
Section: Human Serum Albumin Administration In Chronic Liver Diseasementioning
confidence: 99%